
Funding · 19 August 2026Butterfly Learnings₹65 CrPaediatric behavioural health platformbutterflylearnings.com ↗
FundingHealthcare & Life Sciences
Butterfly Learnings raises ₹65 crore in Pre-Series B funding
By Abha Lohia · Editor ·
Butterfly Learnings: revenue and funding and every story →
Pre-Series BMumbaiFounded 2021
- Butterfly Learnings provides clinical therapy, diagnostics, and inclusive schooling for neurodivergent children through a network of physical centres and…
- The company secured ₹65 crore in a Pre-Series B round led by Inflexor Ventures to scale its operations and technology
- The startup already operates 90 centres across 22 cities, leveraging proprietary screening tools and a large team of therapists
What happened
- Butterfly Learnings raised ₹65 crore in a Pre-Series B funding round.
- Inflexor Ventures led the investment round.
- Enzia Ventures, Insitor Impact Asia Fund, and IIMA Ventures also participated in the round.
- The company provides a full-stack platform for children with neurodevelopmental conditions.
- The startup operates a network of over 90 centres across 22 cities in India.
- The platform employs more than 400 therapists to deliver clinical interventions.
Why it matters
- There are an estimated 45 million children in India with neurodevelopmental conditions.
- Only a small fraction of these children currently receive timely clinical intervention.
- Awareness regarding conditions like autism and ADHD is rising across the country.
The business
- The company offers clinical therapy, inclusive education, and diagnostic services.
- Therapies include applied behaviour analysis (ABA), speech therapy, and occupational therapy.
- It operates the BLISS inclusive schooling system following NIOS and DISHA curricula.
- The company holds an exclusive global licence for Get SET Early, an eye-tracking autism screening tool.
- The screening tool is CDSCO (Central Drugs Standard Control Organisation) approved for children aged 12 to 48 months.
- It runs a BHCOE-accredited institute to train its own therapists.
- The company reported revenue of ₹15.5 crore in FY25, up from ₹6.3 crore in FY24.
The founders
- She is a qualified paediatric neurologist.
- He is a healthcare entrepreneur.
- He previously founded Biosense Technologies.
Who put in money
- Inflexor Ventures lead — Venture capital firm that led the Pre-Series B round.
In numbers
₹15.5 CrRevenue · 2025
₹13.3 CrNet Loss · 2025
What happens next
- Expand the centre network beyond Maharashtra.
- Strengthen AI and digital capabilities.
- Increase deployment of the Get SET Early tool through hospitals.
- Expand the internal therapist training programme.
Earlier rounds
- 2024 · Series A · ₹32 Cr · led by Insitor Impact Asia Fund II and Enzia Ventures
Words to know
- Neurodivergent
- People whose brains function differently from what is considered typical, such as those with autism or ADHD.
- Applied Behaviour Analysis (ABA)
- A therapy based on the science of learning and behaviour used to improve social and communication skills.
- CDSCO
- The national regulatory body for Indian pharmaceuticals and medical devices.
- Pre-Series B
- A funding stage that occurs after Series A but before a full Series B round, typically used to scale operations.
The numbers around it
Healthcare & Life Sciences in August 2026: 10 rounds with a disclosed amount, $139 million in all; the biggest was Biodeal Pharmaceuticals (₹385 crore). Every sector this year →
Other articles talking about it
ascendants.in ↗ascendants.in ↗startup-story-media ↗Indian Startup News ↗YourStory.com ↗Indian Pharma Post ↗indian-startup-times ↗Entrackr ↗Indian Startup Times ↗Inc42 ↗Entrackr ↗
Terms in this story
- Startup: A startup is a young company built to find a new way of doing something and to grow fast, usually by serving many customers at little extra cost. India also has a legal definition for scheme benefits: under ten years old, turnover under ₹200 crore, and working on innovation or a scalable model.
- Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
- Series B/C: Series B, C, D and later rounds are growth rounds: large cheques for a startup with a proven model that wants to expand, enter new markets or move toward profit and a listing. In India they are usually priced in CCPS and, when foreign investors take part, must follow FEMA pricing rules.
- Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.
Read next
FundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centresLaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugar
Everything on Butterfly Learnings → · All startup news on 19 August 2026 →
Is this Butterfly Learnings? Get your “Featured on StopDown” badge →